Voyager Therapeutics Inc has a consensus price target of $16 based on the ratings of 12 analysts. The high is $30 issued by HC Wainwright & Co. on April 8, 2025.The low is $7 issued by Wedbush on ...

Shares in Voyager Technologies soared in their public debut June 11 as the company plans to use the proceeds to support work ...

Voyager plans to use the cash injection from the offering to fund investment in research and development programs and buy ...

Voyager Technologies debuted on the New York Stock Exchange June 11, raising nearly $383 million in an upsized IPO that ...

Shares of Voyager Technologies, a space and defense tech company that counts Palantir and NASA among its customers and ...